Teleflex Inc (TFX) stock
TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3028% below fair value
$155.10+1.95 (+1.27%)
Close on Nov 13, 2026Market cap $6.57BP/E 18.8Yield 0.88%
Teleflex EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Teleflex's EPS for the twelve months ending Sep 30, 2026 was $8.23. For fiscal 2025 it was -$20.25, down 1468.2% from the year before. The highest annual figure on record is $10.23 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.25 | -1468.2% |
| FY2024 | Dec 31, 2024 | $1.48 | -80.3% |
| FY2023 | Dec 31, 2023 | $7.53 | -2.0% |
| FY2022 | Dec 31, 2022 | $7.68 | -24.9% |
| FY2021 | Dec 31, 2021 | $10.23 | +44.3% |
| FY2020 | Dec 31, 2020 | $7.09 | -27.7% |
| FY2019 | Dec 31, 2019 | $9.80 | +128.4% |
| FY2018 | Dec 31, 2018 | $4.29 | +31.2% |
| FY2017 | Dec 31, 2017 | $3.27 | -34.3% |
| FY2016 | Dec 31, 2016 | $4.98 | -2.4% |
| FY2015 | Dec 31, 2015 | $5.10 | +26.2% |
| FY2014 | Dec 31, 2014 | $4.04 | +17.1% |
| FY2013 | Dec 31, 2013 | $3.45 | – |
| FY2012 | Dec 31, 2012 | -$4.65 | -158.7% |
| FY2011 | Dec 31, 2011 | $7.92 | +58.7% |
| FY2010 | Dec 31, 2010 | $4.99 | -34.3% |
| FY2009 | Dec 31, 2009 | $7.59 | +152.2% |
| FY2008 | Dec 31, 2008 | $3.01 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $22.28 | – |
| Q2 FY2026 | Jun 30, 2026 | $2.28 | -17.7% |
| Q1 FY2026 | Mar 31, 2026 | -$0.18 | -108.7% |
| Q4 FY2025 | Dec 31, 2025 | -$16.15 | – |
| Q3 FY2025 | Sep 28, 2025 | -$9.24 | -491.5% |
| Q2 FY2025 | Jun 29, 2025 | $2.77 | +63.9% |
| Q1 FY2025 | Mar 30, 2025 | $2.07 | +546.9% |
| Q4 FY2024 | Dec 31, 2024 | -$2.93 | -543.9% |
| Q3 FY2024 | Sep 29, 2024 | $2.36 | -18.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.69 | -28.1% |
| Q1 FY2024 | Mar 31, 2024 | $0.32 | -80.2% |
| Q4 FY2023 | Dec 31, 2023 | $0.66 | -60.2% |
| Q3 FY2023 | Oct 1, 2023 | $2.90 | +34.3% |
| Q2 FY2023 | Jul 2, 2023 | $2.35 | +5.4% |
| Q1 FY2023 | Apr 2, 2023 | $1.62 | -0.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.66 | -38.5% |
| Q3 FY2022 | Sep 25, 2022 | $2.16 | -48.6% |
| Q2 FY2022 | Jun 26, 2022 | $2.23 | +26.7% |
| Q1 FY2022 | Mar 27, 2022 | $1.63 | +3.2% |
| Q4 FY2021 | Dec 31, 2021 | $2.70 | +67.7% |
| Q3 FY2021 | Sep 26, 2021 | $4.20 | +70.7% |
| Q2 FY2021 | Jun 27, 2021 | $1.76 | +633.3% |
| Q1 FY2021 | Mar 28, 2021 | $1.58 | -43.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.61 | -29.7% |
| Q3 FY2020 | Sep 27, 2020 | $2.46 | -49.3% |
| Q2 FY2020 | Jun 28, 2020 | $0.24 | -86.4% |
| Q1 FY2020 | Mar 29, 2020 | $2.78 | +219.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.29 | +18.7% |
| Q3 FY2019 | Sep 29, 2019 | $4.85 | +300.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.77 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.87 | -27.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.93 | – |
| Q3 FY2018 | Sep 30, 2018 | $1.21 | -26.7% |
| Q2 FY2018 | Jul 1, 2018 | -$0.05 | -103.0% |
| Q1 FY2018 | Apr 1, 2018 | $1.20 | +39.5% |
| Q4 FY2017 | Dec 31, 2017 | -$0.91 | -170.0% |
| Q3 FY2017 | Oct 1, 2017 | $1.65 | – |
| Q2 FY2017 | Jul 2, 2017 | $1.67 | – |
| Q1 FY2017 | Apr 2, 2017 | $0.86 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.30 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?